Filing Flows › DSS (DSS) › Q1 2026 › vs Q1 2025
DSS (DSS) Q1 2026 vs Q1 2025 (year over year)
DSS's revenue fell $623K (-13%) from $5.0M in Q1 2025 to $4.3M in Q1 2026. The biggest changes: Rental Income −$566K (-79%); Commission Revenue −$198K (-90%); Printed Products Revenue Information +$165K (+4%).
DSS, Q1 2026: revenue $4.3M (-13% year over year), operating margin -126.7%, net loss $6.4M, operating cash flow −$133K. The chart draws each line against Q1 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q1 2025 | Change | % |
|---|---|---|---|---|
| Printed Products Revenue Information | $4.2M | $4.0M | $165K | +4% |
| Rental Income | $148K | $714K | −$566K | -79% |
| Commission Revenue | $23K | $221K | −$198K | -90% |
| Biotechnology Retail Sales | $7K | $15K | −$8K | -53% |
| Commercial Lending | $6K | $21K | −$15K | -71% |
| Revenue | $4.3M | $5.0M | −$623K | -13% |
| Net loss | $6.4M | $5.3M | $1.1M | +20% |
| Costs & expenses | $10.7M | $10.3M | $368K | +4% |
| Operating costs | $9.8M | $8.7M | $1.1M | +13% |
| Interest & other, net | $867K | $1.6M | −$770K | -47% |
| SG&A | $4.3M | $3.5M | $792K | +23% |
| Other operating costs | $5.5M | $5.2M | $346K | +7% |
| Operating cash sources | $6.4M | $5.3M | $1.1M | +20% |
| Depreciation & amortization | $633K | $523K | $110K | +21% |
| Share-based compensation | $1.4M | $872K | $568K | +65% |
| Working capital & other | $4.1M | $4.1M | $79K | +2% |
| Cash used in operations | $133K | −$168K | $301K | — |
| Net loss absorbed | $6.4M | $5.3M | $1.1M | +20% |
Questions
How much did DSS's revenue grow year over year in Q1 2026?
DSS's revenue fell $623K (-13%) from $5.0M in Q1 2025 to $4.3M in Q1 2026.
What drove DSS's revenue change in Q1 2026?
Rental Income −$566K (-79%); Commission Revenue −$198K (-90%); Printed Products Revenue Information +$165K (+4%).